Doctors should not automatically rule out surgery for octogenarians with early-stage lung cancer, according to a new study ...

Retevmo improved event-free survival in stage 2 to 3A RET fusion-positive non-small cell lung cancer after curative therapy, per phase 3 data. Retevmo (selpercatinib) significantly improved event-free ...

eyonis® LCS aims to redefine lung cancer screening by supporting diagnosis at early, curable stages, while reducing false positives to avoid unnecessary follow-up procedures, and has the potential to ...

Screening guidelines often fail to pinpoint who’s at risk, and few people who are eligible for screening actually get checked ...